NCT07072000 2025-07-18
Shrinking the Anterior Border of CTV2 for Nasopharyngeal Carcinoma to Reduce the Radiation of Nasal Cavity
Sun Yat-sen University
Phase 3 Not yet recruiting
Clinical Trials
8 trialsNCT06900218 2025-04-02
PD-1 Antibody Sintilimab Combined With Capecitabine as Adjuvant Therapy for High-Risk Nasopharyngeal Carcinoma
Sun Yat-sen University
Phase 3 Not yet recruiting
NCT06775756 2025-01-15
Reducing Dose and Irradiated Volume in Cervical Prophylactic Irradiation for Nasopharyngeal Cancer
Fujian Cancer Hospital
Phase 3 Not yet recruiting
NCT06486220 2024-07-03
PFLL Combined With PD-1 Antibody With or Without FMT for Oligometastatic NPC,a Phase III ,Open, Randomized Clinical Trial.
Sun Yat-sen University
Phase 3 Not yet recruiting
NCT06095167 2023-10-23
Induction Chemotherapy and Immunotherapy Combined Radiotherapy With or Without Concurrent Chemotherapy for Stage III-IVa NPC
Fujian Cancer Hospital
Phase 3 Not yet recruiting
NCT04215510 2021-02-23
Early Recurrent Nasopharyngeal Cancer: the Effect of Surgery vs IMRT
Eye & ENT Hospital of Fudan University
Phase 3 Not yet recruiting
NCT03529279 2018-05-18
CNG Staging Compared With 8th UICC of NPC for Treatment Decision-marking and Selection of Chemotherapy and Radiotherapy
Sun Yat-sen University
Phase 3 Not yet recruiting
NCT03503136 2018-05-11
NX-NPC
Sun Yat-sen University
Phase 3 Not yet recruiting